According to TMTpost App news on March 31, atomization technology company Smore International released its 2021 annual performance report. Annual operating income reached 13.755 billion yuan, a year-on-year increase of 37.4%. After adjustment, per share Profit 0.91 yuan.
The financial report shows that last year, Smore launched a new generation of independently developed automated production lines to realize automated production of the entire production line such as assembly, liquid injection, and packaging. Its single-line production efficiency can reach 7,200 standard atomizers per hour. It has surpassed the industry level and is the first to be applied to core customers on a large scale.
In addition, Smore's TOB business revenue for corporate customers exceeded 10 billion for the first time last year, reaching 12.59 billion yuan, a year-on-year increase of 37.4%; its TOC business revenue for retail customers was 1.16 billion yuan, a year-on-year increase of 37.1% %.
The overall financial report for 2021 shows that Smoor’s expenses on research and development have increased by nearly 60%. Currently, it has applied for a total of 3,408 patents, covering temperature control, heating element, leakage prevention, and liquid storage. For this type of technology, there were 1,187 new patent applications worldwide last year, an increase of 60% from the previous year, and the vast majority of these patents revolved around the "atomization CPU" ceramic atomization core technology.
In terms of specific investment proportion, Smol's investment in research and development expenses in 2021 was 670 million yuan, a year-on-year increase of 59.7%. The main R&D investment focuses on cutting-edge materials science, fluid mechanics, aerodynamics, thermodynamics and other fields.
Among them, 7 basic science research institutes established in China and the United States have been put into operation. By the end of 2021, Smore has 1,254 R&D personnel, including 101 with PhDs or above, a year-on-year increase of 47% and 215% respectively.
According to Sullivan’s relevant report, Smore’s global market share will continue to expand in 2021, reaching 22.8%, exceeding the sum of the second to fifth places. The report also pointed out that the global electronic atomization equipment market will grow rapidly in the next five years, with a compound growth rate of 24.6%. However, a report from Zhiyan Consulting pointed out that the share of atomized products will only be 9.3% by 2024.
To this end, Smol’s 2022 plan will be to implement a full category layout of atomized products. At the same time, Smore will also enter the disposable category overseas in 2022. According to the financial report, Smore will also conduct new exploration and layout in the medical and beauty fields. It is cooperating with well-known domestic and foreign teams to develop medical, beauty and other related products, which are expected to be launched on the market soon.
After the meeting, Titanium Media App conducted an interview with Smoor’s senior management. Faced with the new policy of “E-Cigarette Management Measures” that will be implemented on May 1, Smoore believes that the new policy limits multi-flavor products. , in addition, users now have different preferences for tobacco-flavored products, which will inevitably have a certain impact on the Chinese market.
However, for overseas markets such as Europe and the United States, multi-flavor products are still the mainstream, and Smore remains optimistic about its overseas market business. In 2023 and beyond, as users in the domestic market become accustomed to tobacco-flavored products, Smore's domestic related markets are bound to rebound.
In addition, Smol also said that the previously established taste laboratory will not stand still. For the global market, we will continue to conduct research and development on multi-flavor products to ensure global market share. For the domestic market, it focuses on developing tobacco-flavored products and continuously improving them.
When talking about the application of electronic atomizers in other scenarios, Smore also revealed that the current research and development direction is not only in the field of medical atomizers, but the goal is to develop pharmaceutical combination products, and atomizers have been studied For 2 years, we are now making breakthroughs in atomized medicines. For atomizers in other fields, they have been laid out in three directions: medical, health and beauty.